(Total Views: 697)
Posted On: 06/13/2020 12:15:04 AM
Post# of 153988
Re: chessmaster #37635
Nah, didn't miss ... nor did others; pointed out right away:
https://investorshangout.com/post/view?id=5794584
Yes saw that article which is good... even if no author taking credit and Dr. Chistopher Recknor's name is incorrect:
https://investorshangout.com/post/view?id=5794272
Thought the following regarding 'Breakthrough Therapy Designation' (for cancer) is quite interesting and wish it had been asked on the CC... mentioned twice:
https://investorshangout.com/post/view?id=5794584
Yes saw that article which is good... even if no author taking credit and Dr. Chistopher Recknor's name is incorrect:
https://investorshangout.com/post/view?id=5794272
Thought the following regarding 'Breakthrough Therapy Designation' (for cancer) is quite interesting and wish it had been asked on the CC... mentioned twice:
Quote:
Although BTD was not a question on the conference call, it should have been discussed, because this is a very real possibility.
The company is compiling the data and believes that it will make a compelling argument at an upcoming meeting with the FDA to discuss the preliminary Breakthrough Therapy Designation (BTD) discussion.
(0)
(0)
